Care Access
Media & News
From new hires and strategic partnerships to new clinical trial announcements and scientific research published in medical journals, hear all the latest ways we’re transforming the healthcare industry.
Care Access Brings World Class Alzheimer’s Research to West Central Florida
Decentralized trials have a new home in Sun City Center, Florida. On November 3, Care Access held a ribbon cutting ceremony for a new research site in the active living senior community. The Sun City Chamber of Commerce and local business leaders joined the Care Access team in celebrating the new...
Read MoreCare Access Drives Decentralized Trial Discussions and On-Site COVID-19 Testing at Four Key Industry Events
BOSTON — (BUSINESS WIRE) — Care Access, the world's leader in executing decentralized clinical trials at scale, has announced its upcoming involvement at four key industry conferences: CNS Summit, Outsourcing in Clinical Trials New England (OCTNE), Decentralized Trials & Research Alliance Annual M...
Read MoreCare Access and Eli Lilly and Company Partner to Increase Diversity Within Oncology Clinical Trials
BOSTON -- (BUSINESS WIRE) -- Care Access, the world’s leading decentralized research organization (DRO), today announced its expanded partnership with global biopharma leader Eli Lilly and Company (Lilly) to broaden patient access to clinical trials and increase representation of minority group...
Read MoreDirect-to-Patient Clinical Research: Care Access Shares Solutions at IoT Clinical Trials Conference
Taking research sites directly to local communities may hold the key to decreasing patient burden. An estimated 70 percent of potential trial participants live over two hours away from the nearest research center, forcing many to think twice about enrolling in a clinical study.¹ Traveling to dista...
Read MoreDecentralized and Direct-To-Patient Trials: Care Access CEO & Co-Founder Shares Insights at Future Trials Conference
Care Access CEO and Co-Founder Ahmad Namvargolian is on a mission to remove barriers to clinical trials for sponsors, physicians and patients, and to make research studies accessible for all. This mission was put to the test in the spring of 2020, when the COVID-19 pandemic sent the world screechin...